Frequency of aspirin resistance clopidogrel resistance in patients with coronary artery disease and its clinical significance / Ahmed Salah Eldin Mohamed Salem ; Supervised Amr Elhadidy , Amal Rizk , Mohammed Eldesuky
Material type:
- معدل حدوث المقاومة ضد عقارى الأسبرين و الكلوبيدوجريل لمرضى قصور الشرايين التاجية و مغزاها الإكلينيكى [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.09.M.Sc.2013.Ah.F (Browse shelf(Opens below)) | Not for loan | 01010110061703000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.09.M.Sc.2013.Ah.F (Browse shelf(Opens below)) | 61703.CD | Not for loan | 01020110061703000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Critical Care Medicine
Aspirin and clopidogrel are important components of medical therepy for patients with cardiovascular or cerebrovascular diseases. Despite their use, a significant number of patients experience recurrent adverse ischemic events. Interindividual variability of platelet aggregation in response to these antiplatelet agents may be an explanation for some of these recurrent events, and small trials have linked aspirin and/or clopidogrei resistance, as measured by platelet function tests, to adverse events
Issued also as CD
There are no comments on this title.